Rules for Identifying Potentially Reactive or Promiscuous Compounds

被引:246
作者
Bruns, Robert F. [1 ]
Watson, Ian A. [1 ]
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
HIGH-THROUGHPUT; INHIBITORS; LEADLIKENESS; MECHANISM; ASSAY; DIVERSITY; CYSTEINE; SCREENS; DRUGS; HITS;
D O I
10.1021/jm301008n
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This article describes a set of 275 rules, developed over an 18-year period, used to identify compounds that may interfere with; biological assays, allowing their removal from screening sets., Reasons. for rejection include reactivity (e.g., acyl halides), interference with assay Measurements. (fluorescence, absorbance, quenching), activities that damage proteins (oxidizers, detergents), instability (e.g., latent aldehydes), and lack of druggability (e.g., compounds lacking both oxygen and nitrogen). The structural queries were profiled, for. frequency of occurrence in druglike and nondruglike compound sets and were extensively reviewed by a panel Of experienced medicinal chemists. As a means of profiling the rules and as a filter in its own, right, an index of biological;promiscuity Was developed. The 584 gene targets with screening data at Lilly were assigned to 17 subfamilies, and the number of subfamilies at which a compound was was used as a promiscuity index. For certain compounds, promiscuous activity disappeared after sample repurification, indicating interference from Occult Contaminants. Because this type of interference; is not amenable to substructure search, a "nuiance list" was developed to flag interfering compounds that passed the substructure rules.
引用
收藏
页码:9763 / 9772
页数:10
相关论文
共 36 条
  • [1] AUTOMATION OF THE RESAZURIN REDUCTION TEST USING FLUOROMETRY OF MICROTITRATION TRAYS
    ALIVEHMAS, T
    LOUHI, M
    SANDHOLM, M
    [J]. JOURNAL OF VETERINARY MEDICINE SERIES B-ZENTRALBLATT FUR VETERINARMEDIZIN REIHE B-INFECTIOUS DISEASES AND VETERINARY PUBLIC HEALTH, 1991, 38 (05): : 358 - 372
  • [2] [Anonymous], 1979, CHINESE MED J-PEKING, V92, P811
  • [3] Comprehensive mechanistic analysis of hits from high-throughput and docking screens against β-lactamase
    Babaoglu, Kerim
    Simeonov, Anton
    Lrwin, John J.
    Nelson, Michael E.
    Feng, Brian
    Thomas, Craig J.
    Cancian, Laura
    Costi, M. Paola
    Maltby, David A.
    Jadhav, Ajit
    Inglese, James
    Austin, Christopher P.
    Shoichet, Brian K.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (08) : 2502 - 2511
  • [4] Observations on screening-based research and some concerning trends in the literature
    Baell, Jonathan B.
    [J]. FUTURE MEDICINAL CHEMISTRY, 2010, 2 (10) : 1529 - 1546
  • [5] New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
    Baell, Jonathan B.
    Holloway, Georgina A.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (07) : 2719 - 2740
  • [6] Boloor A. C. M., 2007, Patent No. [US 2007/0015756 A1, 20070015756]
  • [7] The oxidative mechanism of action of ortho-quinone inhibitors of protein-tyrosine phosphatase α is mediated by hydrogen peroxide
    Bova, MP
    Mattson, MN
    Vasile, S
    Tam, D
    Holsinger, L
    Bremer, M
    Hui, T
    McMahon, G
    Rice, A
    Fukuto, JM
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2004, 429 (01) : 30 - 41
  • [8] Committee on Amines, 1981, AR AM ASS BIOL ENV E
  • [9] Structure-activity relationships of pyrithiones-IPC-81 toxicity tests with the antifouling biocide zinc pyrithione and structural analogs
    Doose, CA
    Ranke, J
    Stock, F
    Bottin-Weber, U
    Jastorff, B
    [J]. GREEN CHEMISTRY, 2004, 6 (05) : 259 - 266
  • [10] High-throughput assays for promiscuous inhibitors
    Feng, BY
    Shelat, A
    Doman, TN
    Guy, RK
    Shoichet, BK
    [J]. NATURE CHEMICAL BIOLOGY, 2005, 1 (03) : 146 - 148